MAPLE PLAIN, Minn. -- (BUSINESS WIRE) -- Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled quick-turn manufacturer, today announced its financial results for the fourth quarter and the year ended December 31, 2012.
Highlights include:
“The fourth quarter was a strong finish to a very good year, marked by record quarterly revenue and net income for Proto Labs,” said Brad Cleveland, President and CEO. “It is particularly encouraging that each of our global operations in the United States, Europe and Japan achieved quarterly revenue records. Our global colleagues did a tremendous job during the quarter despite significant economic challenges.”
Additional highlights include:
“Our manufacturing and engineering teams also continued their focus on streamlining our processes and further improving our already excellent margins. The result was yet another increase in our net income, and I would like to congratulate everyone involved on the success of their efforts,” concluded Mr. Cleveland.
Non-GAAP Financial Measure
The company has included non-GAAP net income, adjusted for stock-based compensation expense in this press release to provide investors with additional information regarding the company’s financial results. The company has provided below a reconciliation of non-GAAP net income, adjusted for stock-based compensation expense, to net income, the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP net income, adjusted for stock-based compensation expense, is used by the company’s management and board of directors to understand and evaluate operating performance and trends and provides a useful measure for period-to-period comparisons of the company’s business. Accordingly, the company believes that non-GAAP net income, adjusted for stock-based compensation expense, provides useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.
Conference Call
The company has scheduled a conference call to discuss its fourth quarter financial results today, February 13, at 8:30 a.m. ET. To access the call in the U.S. please dial 800-659-2032. Outside the U.S. please dial 617-614-2712. Use participant code 74470100#. A simultaneous webcast of the call will also be available on the investor relations section of the company’s website at www.protolabs.com/investors. An audio replay will be available for 14 days following the call on the investor relations website of Proto Lab’s website.
About Proto Labs, Inc.
Proto Labs is a leading online and
technology-enabled quick-turn manufacturer of custom parts for
prototyping and short-run production. Proto Labs provides “Real Parts,
Really Fast” to product developers worldwide. Proto Labs utilizes
computer numerical control (CNC) machining and injection molding to
manufacture custom parts for our customers. For more information, visit protolabs.com.
Forward-Looking Statements
Statements contained in this
press release regarding matters that are not historical or current facts
are “forward-looking statements” within the meaning of The Private
Securities Litigation Reform Act of 1995. These statements involve known
and unknown risks, uncertainties and other factors which may cause the
results of Proto Labs to be materially different than those expressed or
implied in such statements. Certain of these risk factors and others are
described in the “Risk Factors” section within reports filed with the
SEC. Other unknown or unpredictable factors also could have material
adverse effects on Proto Labs’ future results. The forward-looking
statements included in this press release are made only as of the date
hereof. Proto Labs cannot guarantee future results, levels of activity,
performance or achievements. Accordingly, you should not place undue
reliance on these forward-looking statements. Finally, Proto Labs
expressly disclaims any intent or obligation to update any
forward-looking statements to reflect subsequent events or circumstances.
| Proto Labs, Inc. | |||||||||
| Condensed Consolidated Balance Sheets | |||||||||
| (In thousands) | |||||||||
| December 31, | December 31, | ||||||||
| 2012 | 2011 | ||||||||
| (Unaudited) | |||||||||
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | $ | 36,759 | $ | 8,135 | |||||
| Short-term marketable securities | 25,137 | 250 | |||||||
| Accounts receivable, net | 15,791 | 11,533 | |||||||
| Inventory | 4,619 | 3,797 | |||||||
| Other current assets | 7,850 | 4,362 | |||||||
| Total current assets | 90,156 | 28,077 | |||||||
| Property and equipment, net | 45,316 | 34,249 | |||||||
| Long-term marketable securities | 36,965 | - | |||||||
| Other long-term assets | 1,493 | - | |||||||
| Total assets | $ | 173,930 | $ | 62,326 | |||||
| Liabilities, redeemable convertible stock and | |||||||||
| shareholder's equity (deficit) | |||||||||
| Current liabilities | |||||||||
| Accounts payable | $ | 4,758 | $ | 4,431 | |||||
| Accrued compensation | 5,995 | 4,767 | |||||||
| Accrued liabilities and other | 513 | 351 | |||||||
| Current portion of long-term debt obligations | 273 | 390 | |||||||
| Total current liabilities | 11,539 | 9,939 | |||||||
| Deferred tax liability | 4,554 | 4,252 | |||||||
| Long-term debt obligations | 356 | 613 | |||||||
| Other | 782 | 871 | |||||||
| Redeemable convertible preferred and common stock | - | 66,894 | |||||||
| Shareholders' equity (deficit) | 156,699 | (20,243 | ) | ||||||
| Total liabilities, redeemable convertible stock and | |||||||||
| shareholders' equity (deficit) | $ | 173,930 | $ | 62,326 | |||||
| Proto Labs, Inc. | ||||||||||||||||||
| Condensed Consolidated Statements of Operations | ||||||||||||||||||
| (In thousands, except share and per share amounts) | ||||||||||||||||||
| (Unaudited) | ||||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||||
| December 31, | December 31, | |||||||||||||||||
|
2012 |
2011 |
2012 |
2011 |
|||||||||||||||
| Revenues | ||||||||||||||||||
| Protomold | $ | 23,674 | $ | 19,002 | $ | 90,371 | $ | 74,090 | ||||||||||
| Firstcut | 9,942 | 6,635 | 35,620 | 24,849 | ||||||||||||||
| Total revenues | 33,616 | 25,637 | 125,991 | 98,939 | ||||||||||||||
| Cost of revenues | 12,611 | 11,073 | 49,853 | 39,324 | ||||||||||||||
| Gross profit | 21,005 | 14,564 | 76,138 | 59,615 | ||||||||||||||
| Operating expenses | ||||||||||||||||||
| Marketing and sales | 4,658 | 4,612 | 18,098 | 15,752 | ||||||||||||||
| Research and development | 2,515 | 1,584 | 9,137 | 5,222 | ||||||||||||||
| General and administrative | 3,564 | 3,475 | 13,957 | 11,772 | ||||||||||||||
| Total operating expenses | 10,737 | 9,671 | 41,192 | 32,746 | ||||||||||||||
| Income from operations | 10,268 | 4,893 | 34,946 | 26,869 | ||||||||||||||
| Other income (expense), net | 114 | (132 | ) | 23 | (114 | ) | ||||||||||||
| Income before income taxes | 10,382 | 4,761 | 34,969 | 26,755 | ||||||||||||||
| Provision for income taxes | 2,987 | 1,531 | 10,944 | 8,783 | ||||||||||||||
| Net income | 7,395 | 3,230 | 24,025 | 17,972 | ||||||||||||||
| Less: dividends on redeemable preferred stock | - | (1,053 | ) | - | (4,179 | ) | ||||||||||||
| Less: undistributed earnings allocated to preferred shareholders | - | (673 | ) | - | (4,507 | ) | ||||||||||||
| Net income attributable to common shareholders | $ | 7,395 | $ | 1,504 | $ | 24,025 | $ | 9,286 | ||||||||||
| Net income per share: | ||||||||||||||||||
| Basic | $ | 0.30 | $ | 0.12 | $ | 1.03 | $ | 0.75 | ||||||||||
| Diluted | $ | 0.29 | $ | 0.11 | $ | 0.98 | $ | 0.67 | ||||||||||
| Shares used to compute net income per share: | ||||||||||||||||||
| Basic | 24,557,878 | 12,895,918 | 23,373,593 | 12,352,004 | ||||||||||||||
| Diluted | 25,359,071 | 14,045,402 | 24,443,665 | 13,939,072 | ||||||||||||||
| Proto Labs, Inc. | ||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||
| (In thousands) | ||||||||||
| (Unaudited) | ||||||||||
| Year Ended | ||||||||||
| December 31, | ||||||||||
| 2012 | 2011 | |||||||||
| Operating activities | ||||||||||
| Net income | $ | 24,025 | $ | 17,972 | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Depreciation and amortization | 6,080 | 4,264 | ||||||||
| Stock-based compensation expense | 3,039 | 1,130 | ||||||||
| Deferred taxes | (582 | ) | 2,230 | |||||||
| Excess tax benefit from stock-based compensation | (6,218 | ) | (657 | ) | ||||||
| Loss on disposal of property and equipment | 154 | (10 | ) | |||||||
| Changes in operating assets and liabilities: | (1,192 | ) | (1,394 | ) | ||||||
| Net cash provided by operating activities | 25,306 | 23,535 | ||||||||
| Investing activities | ||||||||||
| Purchases of property and equipment | (17,397 | ) | (19,003 | ) | ||||||
| Purchases of marketable securities | (84,219 | ) | - | |||||||
| Proceeds from sale of marketable securities | 22,368 | 500 | ||||||||
| Net cash used in investing activities | (79,248 | ) | (18,503 | ) | ||||||
| Financing activities | ||||||||||
| Proceeds from initial public offering, net of offering costs | 71,530 | - | ||||||||
| Proceeds from follow-on offering, net of offering costs | 2,451 | - | ||||||||
| Payments on debt | (388 | ) | (4,049 | ) | ||||||
| Proceeds from exercises of warrants and stock options | 2,975 | 547 | ||||||||
| Excess tax benefit from stock-based compensation | 6,218 | 657 | ||||||||
| Net cash provided by (used in) financing activities | 82,786 | (2,845 | ) | |||||||
| Effect of exchange rate changes on cash and cash equivalents | (220 | ) | (153 | ) | ||||||
| Net increase in cash and cash equivalents | 28,624 | 2,034 | ||||||||
| Cash and cash equivalents, beginning of period | 8,135 | 6,101 | ||||||||
| Cash and cash equivalents, end of period | $ | 36,759 | $ | 8,135 | ||||||
| Proto Labs, Inc. | ||||||||||
| Reconciliation of GAAP to Non-GAAP Financial Measure | ||||||||||
| (In thousands, except share and per share amounts) | ||||||||||
| (Unaudited) | ||||||||||
| Three Months Ended | Year Ended | |||||||||
| December 31, 2012 | December 31, 2012 | |||||||||
| Non-GAAP net income, adjusted for stock-based compensation expense: | ||||||||||
| GAAP net income | $ | 7,395 | $ | 24,025 | ||||||
| Add back: Stock-based compensation expense | ||||||||||
| Cost of revenue | 87 | 335 | ||||||||
| Marketing and sales | 118 | 418 | ||||||||
| Research and development | 140 | 486 | ||||||||
| General and administrative | 332 | 1,800 | ||||||||
| Total stock-based compensation expense | 677 | 3,039 | ||||||||
| Less: Tax benefit on stock-based compensation | (181 | ) | (844 | ) | ||||||
| Non-GAAP net income | $ | 7,891 | $ | 26,220 | ||||||
| Non-GAAP net income per share: | ||||||||||
| Basic | $ | 0.32 | $ | 1.12 | ||||||
| Diluted | $ | 0.31 | $ | 1.07 | ||||||
| Shares used to compute non-GAAP net income per share: | ||||||||||
| Basic | 24,557,878 | 23,373,593 | ||||||||
| Diluted | 25,359,071 | 24,443,665 | ||||||||
| Proto Labs, Inc. | ||||||||||||||||
| Revenue by Geography - Based on Shipping Location | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended | Year Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
|
2012 |
2011 |
2012 |
2011 |
|||||||||||||
| Revenues | ||||||||||||||||
| Domestic | ||||||||||||||||
| United States | $ | 24,979 | $ | 18,287 | $ | 94,866 | $ | 73,010 | ||||||||
| International | ||||||||||||||||
| Europe | 6,212 | 5,512 | 22,517 | 19,453 | ||||||||||||
| Japan | 1,396 | 1,002 | 4,814 | 2,852 | ||||||||||||
| United States | 1,029 | 836 | 3,794 | 3,624 | ||||||||||||
| Total international | 8,637 | 7,350 | 31,125 | 25,929 | ||||||||||||
| Total revenue | $ | 33,616 | $ | 25,637 | $ | 125,991 | $ | 98,939 | ||||||||
| Proto Labs, Inc. | ||||||||||||||
| Customer Information | ||||||||||||||
| (In thousands, except customer amounts) | ||||||||||||||
| (Unaudited) | ||||||||||||||
| Year Ended December 31, | ||||||||||||||
| 2012 | 2011 | |||||||||||||
|
Number of |
Revenue ($) |
Number of |
Revenue ($) | |||||||||||
| New Customers | 2,991 | $ | 20,766 | 2,598 | $ | 18,401 | ||||||||
| Existing Customers | 4,763 | 105,225 | 3,430 | 80,538 | ||||||||||
| Total | 7,754 | $ | 125,991 | 6,028 | $ | 98,939 | ||||||||
Proto Labs, Inc.
Investor Relations:
Jack Judd,
763-479-7408
jack.judd@protolabs.com
or
Media
Relations:
Bill Dietrick, 763-479-7664
bill.dietrick@protolabs.com